Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Fromm

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
European Journal of Clinical Pharmacology|January 1, 1995
Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolitesM F Fromm, S Botsch, G Heinkele, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Personalizing antiplatelet therapy with clopidogrelD Trenk, O Zolk, M F Fromm, et al.
Clinical Pharmacology and Therapeutics|May 24, 2001
Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosingD Busse, M F Fromm, K Mörike, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1996
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolismN Holtbecker, M F Fromm, H K Kroemer, et al.
Diabetes, Obesity & Metabolism|September 11, 2009
Interaction of beta-blockers with the renal uptake transporter OCT2I Bachmakov, H Glaeser, B Endress, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 1999
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadineM Cvetkovic, B Leake, M F Fromm, et al.
Biochemical and Biophysical Research Communications|July 7, 2009
Functionalized silicon quantum dots tailored for targeted siRNA deliveryS Klein, O Zolk, M F Fromm, et al.
European Journal of Pain (London, England)|February 17, 2012
Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain reliefB Renner, G Walter, J Strauss, et al.
Clinical Pharmacology and Therapeutics|July 26, 2014
Inconsistencies and misleading information in officially approved prescribing information from three major drug marketsB Pfistermeister, A Saß, M Criegee-Rieck, et al.
British Journal of Clinical Pharmacology|March 28, 1998
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionM F Fromm, K Dilger, D Busse, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
European Journal of Clinical Pharmacology|January 1, 1995
Influence of renal function on the steady-state pharmacokinetics of the antiarrhythmic propafenone and its phase I and phase II metabolitesM F Fromm, S Botsch, G Heinkele, et al.
Clinical Pharmacology and Therapeutics|September 6, 2012
Personalizing antiplatelet therapy with clopidogrelD Trenk, O Zolk, M F Fromm, et al.
Clinical Pharmacology and Therapeutics|May 24, 2001
Disposition and pharmacologic effects of R/S-verapamil in patients with chronic atrial fibrillation: an investigation comparing single and multiple dosingD Busse, M F Fromm, K Mörike, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 1, 1996
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolismN Holtbecker, M F Fromm, H K Kroemer, et al.
Diabetes, Obesity & Metabolism|September 11, 2009
Interaction of beta-blockers with the renal uptake transporter OCT2I Bachmakov, H Glaeser, B Endress, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 27, 1999
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadineM Cvetkovic, B Leake, M F Fromm, et al.
Biochemical and Biophysical Research Communications|July 7, 2009
Functionalized silicon quantum dots tailored for targeted siRNA deliveryS Klein, O Zolk, M F Fromm, et al.
European Journal of Pain (London, England)|February 17, 2012
Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain reliefB Renner, G Walter, J Strauss, et al.
Clinical Pharmacology and Therapeutics|July 26, 2014
Inconsistencies and misleading information in officially approved prescribing information from three major drug marketsB Pfistermeister, A Saß, M Criegee-Rieck, et al.
British Journal of Clinical Pharmacology|March 28, 1998
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionM F Fromm, K Dilger, D Busse, et al.
Pageof 6